You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Panobinostat (PAN)

Showing 1 - 25 of 382
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (LBH589, Lenalidomide)

Completed
  • Multiple Myeloma
  • San Francisco, California
  • +9 more
Dec 16, 2020

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)

Active, not recruiting
  • Multiple Myeloma
  • panobinostat capsules
  • +2 more
  • Fayetteville, Arkansas
  • +79 more
Mar 15, 2021

Multiple Myeloma in Relapse Trial in Boston, Durham (Panobinostat, Dexamethasone, Lenalidomide)

Completed
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
  • +3 more
Sep 3, 2021

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)

Completed
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Nagoya-city, Aichi, Japan
  • +5 more
Dec 16, 2020

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Jul 9, 2021

Multiple Myeloma Trial in Worldwide (Panobinostat)

No longer available
  • Multiple Myeloma
  • Innsbruck, Tyrol, Austria
  • +39 more
Apr 6, 2020

Multiple Myeloma Trial in United States (panobinostat, carfilzomib)

Completed
Has Results
  • Multiple Myeloma
  • Denver, Colorado
  • +12 more
Jan 4, 2022

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Pan Immune Inflammatory Index and Endometriosis

    Active, not recruiting
    • Relationship Between Pan Immune Inflammatory Index and Endometriosis and Endometriosis Stages
      • Ankara, Yenimahalle, Turkey
        Ankara Etlik City Hospital
      Nov 16, 2023

      Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)

      Recruiting
      • Solid Tumor
      • EGFR Amplification
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 28, 2023

      Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

      Recruiting
      • Solid Tumor
      • +4 more
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 28, 2023

      Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)

      Not yet recruiting
      • Tumor, Solid
      • RCMI in painting dose on histoscannographic mapping
      • Standard pan-sinusal IMRT
      • Caen, France
      • +2 more
      Jul 5, 2023

      Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

      Completed
      Has Results
      • Adult Nasal Type Extranodal NK/T-cell Lymphoma
      • +20 more
      • Scottsdale, Arizona
      • +1 more
      May 6, 2022

      Multiple Myeloma Trial in Worldwide (Panobinostat, Bortezomib, Dexamethasone)

      Completed
      Has Results
      • Multiple Myeloma
      • Phoenix, Arizona
      • +209 more
      Mar 8, 2020

      Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent Trial in Boston

      Active, not recruiting
      • Diffuse Intrinsic Pontine Glioma
      • +5 more
      • Boston, Massachusetts
      • +1 more
      May 3, 2022

      Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)

      Not yet recruiting
      • Cancer
      • +2 more
      • Pan-genomic Testing
      • Scottsdale, Arizona
      • +2 more
      Aug 18, 2023

      Sickle Cell Disease Trial in Augusta (panobinostat)

      Active, not recruiting
      • Sickle Cell Disease
      • Augusta, Georgia
        Augusta University
      May 26, 2021

      Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

      Terminated
      Has Results
      • Clear Cell Renal Cell Carcinoma
      • +3 more
      • Buffalo, New York
      • +1 more
      Aug 11, 2022

      Medulloblastoma Trial in Houston (Treatment with MTX110)

      Recruiting
      • Medulloblastoma
      • Treatment with MTX110
      • Houston, Texas
        The University of Texas Health Science Center at Houston
      Jun 30, 2022

      Diabetes, Type 2 Trial (Methodological intervention, Toujeo)

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Methodological intervention
      • Toujeo
      • (no location specified)
      Mar 21, 2023

      Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

      Recruiting
      • Cancer
      • +2 more
      • Cellworks Report
      • Sioux Falls, South Dakota
        Avera Cancer Institute
      Jan 20, 2023

      Advanced Solid Tumors Trial in Worldwide (panobinostat (LBH589))

      Completed
      • Advanced Solid Tumors
      • panobinostat (LBH589)
      • Salt Lake City, Utah
      • +4 more
      Dec 16, 2020

      Advanced Solid Tumors Trial in Worldwide (LBH589)

      Completed
      • Advanced Solid Tumors
      • Salt Lake City, Utah
      • +5 more
      Dec 16, 2020

      MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)

      Completed
      Has Results
      • Myelodysplastic Syndromes
      • +2 more
      • Augusta, Georgia
      • +37 more
      Jul 20, 2020